Ruyan America, Inc. Enters into Agreement with Nashville-based Nathan & James Group

February 15, 2008

MINNEAPOLIS, MN.Ruyan America, Inc. announced today that it has entered into an agreement with Nathan & James Group LLC, Nashville, TN, under which Nathan & James will develop and make available via Direct Response Television, i.e. infomercials, the Ruyan E-cigarette and its replacement cartridges in the United States. This arrangement is an exclusive arrangement wherein Ruyan and NJG will cooperate closely, working with leaders in the Direct Response industry and leaders in their allied businesses- telemarketing, fulfillment, payment process and shipping.

Alexander Chong, CEO, Ruyan America, stated, “We are pleased to enter into this agreement. NJG has assembled a dynamic and effective team. Additionally, they have identified serious and successful partners who will make DRTV a successful venue for our products.”

Llyn Patterson, partner at Nathan & James, commented, “We’re excited to make today’s announcement. Our research indicates that the E-cigarette can and will be successfully introduced and sold via direct television channels. We look forward to working with Ruyan America and our other partners to make this a mutually beneficial partnership.”

Ruyan America, Inc is a US-based joint venture partner of Ruyan Holdings Ltd of Hong Kong. Ruyan America’s Chairman, Mr. Hon Lik, is the inventor and patent holder of the E-cigarette and the atomizing technology that is critical to it, the E-cigar and the E-pipe. These products, varieties of replacement cartridges and their accessories are designed, manufactured and sold for the cigarette replacement/smoking substitution market. They allow smokers to satisfy their cravings for nicotine in places and situations where they otherwise cannot smoke by law, regulation or common courtesy. Ruyan is the only manufacturer of E-cigarette pursuant to Mr. Hon’s patents and Ruyan America is the only Company providing E-cigarettes, E-cigars, E-pipes, their cartridges and accessories to distributors and retailers in concert with safety test results, product liability insurance, detailed ingredient lists, documentation of proprietary intellectual property and the support of a $4 million Direct Response Television campaign.

Warning: be advised that nicotine is addictive. The Ruyan products have not been evaluated by the US FDA. They are not intended to be drug products that diagnose, treat, cure or mitigate any disease or condition. Do not use these products if you are under the age of 21; if you are a non-smoker, if you have a demonstrated allergy or sensitivity to nicotine or any combination of inhalants; or if you are pregnant or nursing.
Copyright © 2009 Ruyan America. All Rights Reserved